Grand Strand Urology

Myrtle Beach, South Carolina 29572

0 studies enrolling now · 12 studies all time

What they study most

Bladder Cancer, Bladder Neoplasms, Bladder Tumors, Castration-Resistant Prostate Cancer, Metastatic Androgen Independent Prostate Cancer, Prostate Cancer, Prostatic Adenocarcinoma, Prostatic Neoplasm, Prostatic Neoplasms, Urinary Bladder Cancer

Studies at this site

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
• Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer — Completed
• A Trial of Degarelix in Patients With Prostate Cancer — Completed
• The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer — Completed
• Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer — Completed
• Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy — Completed
• A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis — Completed
• Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer — Completed